Scientists all over the world are working on drugs to inhibit or treat degenerative diseases of the brain. According to WHO data, 55 million people worldwide suffer from Alzheimer’s, with 10 million new cases detected yearly. However, the new chemical molecules are not the only possible treatment since so-called digital therapeutics (DTx) have begun to enter medicine.
At the Clinical Trials on Alzheimer’s Disease conference in San Francisco, the company announced the start of a clinical trial of the device. About 500 participants will wear the headset for one hour a day. Cognito device is non-invasive and looks like a pair of sunglasses.
New light-and-sound therapy could help patients with alzheimer’s
Monday, December 19, 2022
News